Investing
Today's Best Market Rumors (7/16/2012) GlaxoSmithKline Buys Human Genome Sciences
Published:
Updated throughout the day on the 24/7 Wall St. Wire:
GlaxoSmithKline (NYSE: GSK) will buy Human Genome Sciences (NASDAQ: HGSI) for $2.8 billion. (Reuters)
The Justic Department and HSBC (NYSE: HBC) are close to a settlement on money laundering for drug cartel charges. (WSJ)
Douglas A. McIntyre
Are you ready for retirement? Planning for retirement can be overwhelming, that’s why it could be a good idea to speak to a fiduciary financial advisor about your goals today.
Start by taking this retirement quiz right here from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes. Smart Asset is now matching over 50,000 people a month.
Click here now to get started.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.